Cargando…

Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients

Detalles Bibliográficos
Autores principales: Grimaldi, Antonio Maria, Simeone, Ester, Festino, Lucia, Giannarelli, Diana, Palla, Marco, Caracò, Corrado, Curvietto, Marcello, Esposito, Assunta, Grimaldi, Maria Chiara, Mozzillo, Nicola, Ascierto, Paolo A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649387/
http://dx.doi.org/10.1186/2051-1426-3-S2-P186
_version_ 1782401347437461504
author Grimaldi, Antonio Maria
Simeone, Ester
Festino, Lucia
Giannarelli, Diana
Palla, Marco
Caracò, Corrado
Curvietto, Marcello
Esposito, Assunta
Grimaldi, Maria Chiara
Mozzillo, Nicola
Ascierto, Paolo A
author_facet Grimaldi, Antonio Maria
Simeone, Ester
Festino, Lucia
Giannarelli, Diana
Palla, Marco
Caracò, Corrado
Curvietto, Marcello
Esposito, Assunta
Grimaldi, Maria Chiara
Mozzillo, Nicola
Ascierto, Paolo A
author_sort Grimaldi, Antonio Maria
collection PubMed
description
format Online
Article
Text
id pubmed-4649387
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46493872015-11-24 Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients Grimaldi, Antonio Maria Simeone, Ester Festino, Lucia Giannarelli, Diana Palla, Marco Caracò, Corrado Curvietto, Marcello Esposito, Assunta Grimaldi, Maria Chiara Mozzillo, Nicola Ascierto, Paolo A J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649387/ http://dx.doi.org/10.1186/2051-1426-3-S2-P186 Text en Copyright © 2015 Grimaldi et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Grimaldi, Antonio Maria
Simeone, Ester
Festino, Lucia
Giannarelli, Diana
Palla, Marco
Caracò, Corrado
Curvietto, Marcello
Esposito, Assunta
Grimaldi, Maria Chiara
Mozzillo, Nicola
Ascierto, Paolo A
Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients
title Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients
title_full Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients
title_fullStr Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients
title_full_unstemmed Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients
title_short Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients
title_sort correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649387/
http://dx.doi.org/10.1186/2051-1426-3-S2-P186
work_keys_str_mv AT grimaldiantoniomaria correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients
AT simeoneester correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients
AT festinolucia correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients
AT giannarellidiana correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients
AT pallamarco correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients
AT caracocorrado correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients
AT curviettomarcello correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients
AT espositoassunta correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients
AT grimaldimariachiara correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients
AT mozzillonicola correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients
AT asciertopaoloa correlationbetweenimmunerelatedadverseeventsandresponsetopembrolizumabinadvancedmelanomapatients